Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Reply to S.C. Clasen et al

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Is DBCG abreast of new developments?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007-2016

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Marco Colleoni
  • Anita Giobbie-Hurder
  • Meredith M Regan
  • Beat Thürlimann
  • Henning Mouridsen
  • Louis Mauriac
  • John F Forbes
  • Robert Paridaens
  • István Láng
  • Ian Smith
  • Jacquie Chirgwin
  • Tadeusz Pienkowski
  • Andrew Wardley
  • Karen N Price
  • Richard D Gelber
  • Alan S Coates
  • Aron Goldhirsch
Vis graf over relationer
Among postmenopausal women with endocrine-responsive breast cancer, the aromatase inhibitor letrozole, when compared with tamoxifen, has been shown to significantly improve disease-free survival (DFS) and time to distant recurrence (TDR). We investigated whether letrozole monotherapy prolonged overall survival (OS) compared with tamoxifen monotherapy.
OriginalsprogEngelsk
TidsskriftJournal of Clinical Oncology
Vol/bind29
Udgave nummer9
Sider (fra-til)1117-24
Antal sider8
ISSN0732-183X
DOI
StatusUdgivet - mar. 2011

ID: 33284342